TruTrace Technologies Inc (CSE:TTT) (OTCMKTS:TTTSF) CEO Robert Galarza thanked shareholders for their support on Tuesday after the company launched a new real-world implementation of its StrainSecure platform with Canada’s largest pharmacy chain Shoppers Drug Mart.
Earlier this week the University Health Network, in partnership with Medical Cannabis by Shoppers Drug Mart, began nationwide clinical trials studying the effects of cannabis use on chronic plain, sleep issues, anxiety and depression.
The trial will use TruTrace’s StrainSecure cannabis tracing and verification platform, an integrated blockchain platform that registers and tracks cannabis intellectual property from genome to sale.
READ: TruTrace Technologies strikes license deal with logistics group OrionOne, which will help it expand beyond cannabis space
The deployment represents a real-world implementation of StrainSecure within the Shoppers ecosystem with an aim to become a fundamental part of legalized medical cannabis for years to come, Galarza wrote in a letter to shareholders.
“(Over) the past two years we at TruTrace have been on a path to bring greater transparency and interoperability to the medical cannabis sector,” Galarza wrote.
“Our mission is aimed squarely at delivering innovative technology to bring visibility and collaboration to this emerging industry. They say nothing worth having comes easy and further, if there is one word that defines every member of our team it is simply...resiliency.”
In addition to the new study, Vancouver-based TruTrace recently inked a strategic partnership with OrionOne Global, opening up market opportunities for TruTrace in other key industries such as freight and logistics.
In the letter, Galarza hailed the landmark deal and the Shoppers/UHN deployment.
“This is our moment,” the CEO wrote. “This is our chance to dig deeper, stay committed to road ahead, stay resilient and continue on a path to achieving our goals.”
Shares of TruTrace were trading 8.3% higher in Toronto at C$0.07 at the midday point Thursday.
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas